Single Point Insulin Sensitivity Estimator (SPISE) As a Prognostic Marker for Emerging Dysglycemia in Children with Overweight or Obesity.

MLA

Stein, Robert, et al. “Single Point Insulin Sensitivity Estimator (SPISE) As a Prognostic Marker for Emerging Dysglycemia in Children with Overweight or Obesity.” Metabolites (2218-1989), vol. 13, no. 1, Jan. 2023, p. 100. EBSCOhost, https://doi.org/10.3390/metabo13010100.

APA

Stein, R., Koutny, F., Riedel, J., Dörr, N., Meyer, K., Colombo, M., Vogel, M., Anderwald, C. H., Blüher, M., Kiess, W., Körner, A., & Weghuber, D. (2023). Single Point Insulin Sensitivity Estimator (SPISE) As a Prognostic Marker for Emerging Dysglycemia in Children with Overweight or Obesity. Metabolites (2218-1989), 13(1), 100. https://doi.org/10.3390/metabo13010100

Chicago

Stein, Robert, Florian Koutny, Johannes Riedel, Natascha Dörr, Klara Meyer, Marco Colombo, Mandy Vogel, et al. 2023. “Single Point Insulin Sensitivity Estimator (SPISE) As a Prognostic Marker for Emerging Dysglycemia in Children with Overweight or Obesity.” Metabolites (2218-1989) 13 (1): 100. doi:10.3390/metabo13010100.